Inspire Announces Webcasts of Presentations at BIO CEO and Roth Growth Stock Conferences

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire senior management will present at the 10^th Annual BIO CEO & Investor Conference on Wednesday, February 13, 2008 at 11:00 am ET in New York City and at the Roth 20th Annual Growth Stock Conference on Wednesday, February 20, 2008 at 12:30 pm PT (3:30 pm ET) in Dana Point, CA.

The webcasts of the presentations will be available on Inspire's web site at www.inspirepharm.com. Archived versions of the webcast presentations will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. Inspire employs a U.S. sales force for the promotion of AzaSite^® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat^® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis^® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Inspire is focused on the therapeutic areas of ophthalmology and respiratory/allergy, and is developing products for dry eye, cystic fibrosis, allergic rhinitis and glaucoma. Elestat and Restasis are registered trademarks owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit www.inspirepharm.com.